Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70451 - 70475 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	EXOC6	54536	downregulated	Silicon Dioxide analog results in decreased expression of EXOC6 mRNA	10q23.33	A24195
Silicon dioxide	Approved	EXOG	9941	downregulated	Silicon Dioxide results in decreased expression of EXOG mRNA	3p22.2	A24196
Silicon dioxide	Approved	EXOSC3	51010	upregulated	Silicon Dioxide analog results in increased expression of EXOSC3 mRNA	9p13.2	A24195
Silicon dioxide	Approved	EXOSC5	56915	downregulated	Silicon Dioxide results in decreased expression of EXOSC5 mRNA	19q13.2	A24196
Silicon dioxide	Approved	EXOSC6	118460	upregulated	Silicon Dioxide analog results in increased expression of EXOSC6 mRNA	16q22.1	A24195
Silicon dioxide	Approved	EXOSC7	23016	upregulated	Silicon Dioxide results in increased expression of EXOSC7 mRNA	3p21.31	A24196
Silicon dioxide	Approved	EXPH5	23086	downregulated	Silicon Dioxide analog results in decreased expression of EXPH5 mRNA	11q22.3	A24195
Silicon dioxide	Approved	EXTL1	2134	downregulated	Silicon Dioxide analog results in decreased expression of EXTL1 mRNA	1p36.11	A24195
Silicon dioxide	Approved	EXTL2	2135	downregulated	Silicon Dioxide results in decreased expression of EXTL2 mRNA	1p21.2	A24196
Silicon dioxide	Approved	EZR	7430	upregulated	Silicon Dioxide analog results in increased expression of EZR mRNA	6q25.3	A24195
Silicon dioxide	Approved	F10	2159	downregulated	Silicon Dioxide analog results in decreased expression of F10 mRNA	13q34	A24195
Silicon dioxide	Approved	F11R	50848	downregulated	Silicon Dioxide analog results in decreased expression of F11R mRNA	1q23.3	A24195
Silicon dioxide	Approved	F2	2147	downregulated	Silicon Dioxide analog results in decreased expression of F2 mRNA	11p11.2	A24195
Silicon dioxide	Approved	F2RL2	2151	upregulated	Silicon Dioxide analog results in increased expression of F2RL2 mRNA	5q13.3	A24194
Silicon dioxide	Approved	F3	2152	upregulated	Silicon Dioxide analog results in increased expression of F3 mRNA	1p21.3	A24194
Silicon dioxide	Approved	F7	2155	downregulated	Silicon Dioxide analog results in decreased expression of F7 mRNA	13q34	A24195
Silicon dioxide	Approved	FA2H	79152	upregulated	Silicon Dioxide analog results in increased expression of FA2H mRNA	16q23.1	A24195
Silicon dioxide	Approved	FAAH2	158584	downregulated	Silicon Dioxide analog results in decreased expression of FAAH2 mRNA	Xp11.21	A24195
Silicon dioxide	Approved	FABP5	2171	upregulated	Silicon Dioxide analog results in increased expression of FABP5 mRNA	8q21.13	A24195
Silicon dioxide	Approved	FADS2	9415	downregulated	Silicon Dioxide analog results in decreased expression of FADS2 mRNA	11q12.2	A24195
Silicon dioxide	Approved	FAM102A	399665	downregulated	Silicon Dioxide results in decreased expression of FAM102A mRNA	9q34.11	A24196
Silicon dioxide	Approved	FAM106A	80039	upregulated	Silicon Dioxide analog results in increased expression of FAM106A mRNA	17p11.2	A24195
Silicon dioxide	Approved	FAM110C	642273	downregulated	Silicon Dioxide analog results in decreased expression of FAM110C mRNA	2p25.3	A24195
Silicon dioxide	Approved	FAM111A	63901	upregulated	Silicon Dioxide results in increased expression of FAM111A mRNA	11q12.1	A24196
Silicon dioxide	Approved	FAM117A	81558	downregulated	Silicon Dioxide analog results in decreased expression of FAM117A mRNA	17q21.33	A24195

Displaying entries 70451 - 70475 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability